Analysen von Matthew Sykes
| 01.11.23 | QIAGEN Neutral | Goldman Sachs Group Inc. | |
| 08.02.23 | QIAGEN Neutral | Goldman Sachs Group Inc. | |
| 09.02.22 | QIAGEN Neutral | Goldman Sachs Group Inc. | |
| 01.12.21 | QIAGEN Neutral | Goldman Sachs Group Inc. | |
| 03.06.21 | QIAGEN Neutral | Goldman Sachs Group Inc. |